1-15 of 70
The Cortisol Clue: Diagnosing Hypercortisolism in People with Difficult-to-Control Cardiometabolic Conditions
CME/CEThe Cortisol Clue: Diagnosing Hypercortisolism in People with Difficult-to-Control Cardiometabolic Conditions
Hanford Yau, MD, CCD, FACP, FACE
Eden Miller, DO, D-ACD, D-ABOM
Jennifer Goldman, PharmD, CDCES, BC-ADM-FCCP
Francisco Javier Ampudia-Blasco, MD, PhD
Continuing the Search: New Data on Hypercortisolism Prevalence in Difficult-to-Control Metabolic Conditions
CME/CEContinuing the Search: New Data on Hypercortisolism Prevalence in Difficult-to-Control Metabolic Conditions
Christian Mende, MD, FACP, FACN, FASN, FASH, FAHA
Deepak Bhatt, MD, MPH, MBA, FACC, FAHA
DKA in the Real World: Evidence and Cases that Matter
CME/CEDKA in the Real World: Evidence and Cases that Matter
Carol Wysham, MD
Samuel Seidu, MD, FRCP(Edin), FRCGP
Grooving Through Lipid Management: A New Rhythm in ASCVD Risk Reduction
CME/CEGrooving Through Lipid Management: A New Rhythm in ASCVD Risk Reduction
Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
Viet Le, DMSc, MPAS, PA-C, FACC, FAHA, HF-Cert
Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC
Pam R. Taub, MD, FACC, FASPC
Leveraging CGM to Its Full Potential in People with T2D
CME/CELeveraging CGM to Its Full Potential in People with T2D
John E. Anderson, MD
Davida F. Kruger, CNP
- advertisement
DKA in Focus: What the New Consensus Means for Practice
CME/CEDKA in Focus: What the New Consensus Means for Practice
Ketan Dhatariya, MBBS, MSc, MD, MS, FRCP, PhD
Jennifer Sherr, MD, PhD
Applying Advances in Practice: Case-Based Look at Selecting Therapy for Cushing Syndrome
CME/CEApplying Advances in Practice: Case-Based Look at Selecting Therapy for Cushing Syndrome
Lewis S. Blevins, Jr, MD
James W. Suliburk, MD, FACS
Breaking Ground: 2025 Milestones in Cushing Syndrome and Looking Forward to 2026
CME/CEBreaking Ground: 2025 Milestones in Cushing Syndrome and Looking Forward to 2026
Deepak Bhatt, MD, MPH, MBA, FACC, FAHA
Amir H. Hamrahian, MD
No Patient with CKD Left Behind! Emerging CKD Therapies in T1D
CME/CENo Patient with CKD Left Behind! Emerging CKD Therapies in T1D
Richard E. Pratley, MD
David Cherney, MD, PhD
prof. Hiddo Heerspink
Advances in Treatment of Hypoparathyroidism: Importance of Genetic Testing for Autosomal Dominant Hypocalcemia Type 1
CME/CE Broadcast ReplayAdvances in Treatment of Hypoparathyroidism: Importance of Genetic Testing for Autosomal Dominant Hypocalcemia Type 1
Michael T. Collins, MD
The Hidden Threat: Transforming CKD Care Across the Diabetes Spectrum
CME/CEThe Hidden Threat: Transforming CKD Care Across the Diabetes Spectrum
prof. Hiddo Heerspink
Peter Rossing, MD, DMSc
Paola Fioretto, MD
- advertisement
Case-Based Approach: Optimizing Cardio-Kidney-Metabolic Outcomes in Individuals With T2D & CKD
CME/CECase-Based Approach: Optimizing Cardio-Kidney-Metabolic Outcomes in Individuals With T2D & CKD
Rajiv Agarwal, MBBS, MD, FASN, BRCU
Prof. Dr. Francesc Xavier Cos Claramunt
Global Perspectives on New Data in Type 2 Diabetes — Congress-to-Clinic Insights From ADA and EASD 2025
CME/CEGlobal Perspectives on New Data in Type 2 Diabetes — Congress-to-Clinic Insights From ADA and EASD 2025
Martin J. Abrahamson, MD, FACP, FRCP
Stefano Del Prato, MD
Linong Ji, MD
Risk Reduction with GLP-1 RAs in Individuals with ASCVD and T2D: 2025 Update
CME/CERisk Reduction with GLP-1 RAs in Individuals with ASCVD and T2D: 2025 Update
Brian P. McDonough, MD, FAAFP
Silvio Inzucchi, MD
Darren McGuire, MD, MHSc
